We are live on ! Find out more
EF

Empowered Funds Portfolio holdings

AUM $19B
1-Year Est. Return 51.73%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+51.73%
3 Year Est. Return
+126.9%
5 Year Est. Return
+174.81%
10 Year Est. Return
AUM
$19B
AUM Growth
+$3.31B
Cap. Flow
+$1.12B
Cap. Flow %
5.9%
Top 10 Hldgs %
17.41%
Holding
2,320
New
218
Increased
1,053
Reduced
749
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 26.2%
2 Financials 12.42%
3 Consumer Discretionary 10.13%
4 Miscellaneous 10.05%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNDT icon
1876
Conduent
CNDT
$302M
$286K ﹤0.01%
195,802
-375,000
-66% -$582K
NRC icon
1877
NRC Health Common Stock
NRC
$476M
$285K ﹤0.01%
13,198
-84
-0.6% -$1.56K
EEFT icon
1878
Euronet Worldwide
EEFT
$2.76B
$284K ﹤0.01%
+3,881
New +$271K
PLXS icon
1879
Plexus
PLXS
$6.56B
$284K ﹤0.01%
+944
New +$246K
VNO icon
1880
Vornado Realty Trust
VNO
$6.83B
$282K ﹤0.01%
7,165
-5,181
-42% -$167K
MYRG icon
1881
MYR Group
MYRG
$4.46B
$281K ﹤0.01%
561
-1,379
-71% -$566K
AIR icon
1882
AAR Corp
AIR
$5.09B
$280K ﹤0.01%
+1,958
New +$231K
SFBC
1883
Sound Financial Bancorp
SFBC
$123M
$278K ﹤0.01%
6,450
COGT icon
1884
Cogent Biosciences
COGT
$6.03B
$278K ﹤0.01%
7,176
+716
+11% +$25.1K
PTGX icon
1885
Protagonist Therapeutics
PTGX
$9.43B
$278K ﹤0.01%
2,264
-57
-2% -$5.95K
FLGT icon
1886
Fulgent Genetics
FLGT
$543M
$276K ﹤0.01%
+13,446
New +$228K
HXL icon
1887
Hexcel
HXL
$6.96B
$275K ﹤0.01%
2,751
-1,375
-33% -$125K
KEX icon
1888
Kirby Corp
KEX
$7.43B
$275K ﹤0.01%
2,024
-92
-4% -$13.2K
CORZ icon
1889
Core Scientific
CORZ
$5.75B
$275K ﹤0.01%
10,751
-12,344
-53% -$291K
APGE
1890
DELISTED
Apogee Therapeutics
APGE
$274K ﹤0.01%
+2,065
New +$186K
AVT icon
1891
Avnet
AVT
$7.56B
$272K ﹤0.01%
3,064
-3,769
-55% -$308K
GEF.B icon
1892
Greif Class B
GEF.B
$4.12B
$271K ﹤0.01%
2,901
HIMS icon
1893
Hims & Hers Health
HIMS
$6.47B
$271K ﹤0.01%
+7,814
New +$210K
HUBG icon
1894
HUB Group
HUBG
$2.24B
$270K ﹤0.01%
6,170
-21
-0.3% -$881
GEF icon
1895
Greif
GEF
$4.83B
$270K ﹤0.01%
3,627
-475
-12% -$31.9K
LNTH icon
1896
Lantheus
LNTH
$6.59B
$270K ﹤0.01%
2,434
-9,545
-80% -$889K
AM icon
1897
Antero Midstream
AM
$10.7B
$269K ﹤0.01%
11,833
-13,065
-52% -$284K
KD icon
1898
Kyndryl
KD
$2.86B
$269K ﹤0.01%
+23,757
New +$296K
KYMR icon
1899
Kymera Therapeutics
KYMR
$9.76B
$268K ﹤0.01%
2,338
-100
-4% -$8.59K
STWD icon
1900
Starwood Property Trust
STWD
$5.95B
$265K ﹤0.01%
16,161

Similar funds

Empowered Funds's Q2 2026 Portfolio in Review

As of Q2 2026, Empowered Funds held 2,320 positions worth $19B, up 21% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Empowered Funds deployed $1.12B of net new capital in Q2 2026, opening 218 new positions and adding to 1,053 existing holdings. Its largest new stake was Invesco QQQ Trust: 83,446 shares worth $61.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $41M trimmed.

  • Empowered Funds's largest Q2 2026 buy was Invesco QQQ Trust: 83,446 shares worth $61.4M.
  • Empowered Funds added most to TSMC in Q2 2026, an estimated $264M increase.
  • Empowered Funds's biggest Q2 2026 reduction was Microsoft, cutting an estimated $41M.
  • Empowered Funds fully exited GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF in Q2 2026, selling an estimated $26.4M.
  • Empowered Funds's ten largest holdings make up 17% of its $19B portfolio in Q2 2026.
  • Empowered Funds opened 218 new positions and closed 208 in Q2 2026.
  • Empowered Funds's portfolio value rose 21% quarter-over-quarter to $19B.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.